{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:47:05Z","timestamp":1787827625826,"version":"build-2784847793"},"reference-count":12,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010913","name":"HCA International Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institutional funds from the Massachusetts General Hospital"},{"name":"Amy Gallagher Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2020,5,20]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Chimeric antigen receptor-modified T cells (CAR-T) have emerged as a promising immunotherapeutic approach in relapsed\/refractory haematolgical malignancies. Broader application is limited by unique toxicities, notably, neurotoxicity (NTX). Language dysfunction is among the most frequent symptoms of NTX, the underlying mechanisms of which remain to be elucidated. Electroencephalogram (EEG) is an important tool to monitor for NTX and may provide insights into language dysfunction.<\/jats:p>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We aimed to characterise language dysfunction and define electroencephalographic signatures after CAR-T cell therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed the clinical presentation and EEG findings of 20 adult patients presenting with language dysfunction after CAR-T cell infusion. The cohort included a subset of patients treated with investigational CD19-directed CAR-T cells for non-Hodgkin\u2019s lymphoma (n=17), acute lymphoblastic leukaemia (n=1), follicular lymphoma (n=1) and chronic lymphocytic leukaemia (n=1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Language dysfunction presented within 14 days of CAR-T cell infusion in 16 (84%) patients. Ten (50%) patients had mild word-finding difficulties and 10 (50%) had marked dysphasia with profound word-finding difficulties; the latter were all associated with generalised rhythmic delta activity or generalised periodic discharges on EEG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Language dysfunction after CAR-T cell therapy is associated with generalised EEG abnormalities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2020-000054","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T05:35:14Z","timestamp":1592544914000},"page":"e000054","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity"],"prefix":"10.1136","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1509-9416","authenticated-orcid":false,"given":"Elisaveta","family":"Sokolov","sequence":"first","affiliation":[{"name":"Department of Neurology, Harvard University, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Karschnia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Harvard University, Cambridge, Massachusetts, USA"},{"name":"Department of Neurosurgery, Ludwig Maximilians University Munich, Munchen, Bayern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Haematology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D M","family":"Hadden","sequence":"additional","affiliation":[{"name":"Neurology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C D","family":"Elwes","sequence":"additional","affiliation":[{"name":"Neurology, King\u2019s College Hospital, London, UK"},{"name":"Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Drummond","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Paiva","sequence":"additional","affiliation":[{"name":"Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pennisi","sequence":"additional","affiliation":[{"name":"Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Herlopian","sequence":"additional","affiliation":[{"name":"Neurology\/Epilepsy Division, Yale University, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Frigault","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard University, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Haematology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafqat","family":"Inam","sequence":"additional","affiliation":[{"name":"Department of Haematology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Cole","sequence":"additional","affiliation":[{"name":"Neurology, Massachusetts General Hospital, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Neuro-oncology\/Neurology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"2025072811570169000_2.1.e000054.1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2025072811570169000_2.1.e000054.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"2025072811570169000_2.1.e000054.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-12-893396"},{"key":"2025072811570169000_2.1.e000054.4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.0000000000005910","article-title":"Eeg findings in car T-cell therapy-related encephalopathy","volume":"91","author":"Herlopian","year":"2018","journal-title":"Neurology"},{"key":"2025072811570169000_2.1.e000054.5","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0b013e3182784729"},{"key":"2025072811570169000_2.1.e000054.6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0421"},{"key":"2025072811570169000_2.1.e000054.7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz053"},{"key":"2025072811570169000_2.1.e000054.8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamaneurol.2016.4990","article-title":"Critical care EEG monitoring research Consortium. Association of periodic and rhythmic electroencephalographic patterns with seizures in critically ill patients","volume":"74","author":"Rodriguez Ruiz","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025072811570169000_2.1.e000054.9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cnp.2017.05.001","article-title":"Population of the ictal-interictal zone: the significance of periodic and rhythmic activity","volume":"2","author":"Johnson","year":"2017","journal-title":"Clin Neurophysiol Pract"},{"key":"2025072811570169000_2.1.e000054.10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13054-017-1678-1","article-title":"New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management. intensive care in hematological and oncological patients (iCHOP) Collaborative group","volume":"21","author":"Kroschinsky","year":"2017","journal-title":"Crit Care"},{"key":"2025072811570169000_2.1.e000054.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182735cd7"},{"key":"2025072811570169000_2.1.e000054.12","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6042"}],"updated-by":[{"DOI":"10.1136\/bmjno-2020-000054corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000}},{"DOI":"10.1136\/bmjno-2020-000054corr2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000}}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2020-000054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:57:08Z","timestamp":1753729028000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2020-000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bmjno-2020-000054"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2020-000054","relation":{"correction":[{"id-type":"doi","id":"10.1136\/bmjno-2020-000054corr1","asserted-by":"object"},{"id-type":"doi","id":"10.1136\/bmjno-2020-000054corr2","asserted-by":"object"}]},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}